Injection-site residues - Scientific guideline
Table of contents
This guidance addresses the assessment of potential consumer risk from veterinary drug residues remaining at intramuscular and subcutaneous injection sites and the elaboration of appropriate pre-slaughter withdrawal periods.
Keywords: Injection site residues, withdrawal periods
-
List item
Adopted guideline on injection site residues - Revision 1 (PDF/397.49 KB)
Adopted
First published: 25/03/2022
Legal effective date: 01/08/2022
EMA/CVMP/SWP/185470/2004 Rev.1 -
List item
Overview of comments received on the guideline on injection site residues (EMA/CVMP/SWP/185470/2004) - Revision 1 (PDF/191.03 KB)
First published: 25/03/2022
EMA/CVMP/SWP/11010/2022 -
List item
Draft guideline on injection site residue - Revision 1 (PDF/429.32 KB)
Draft: consultation closed
First published: 15/10/2021
Consultation dates: 15/10/2021 to 17/12/2021
EMA/CVMP/SWP/185470/2004 Rev.1 -
List item
Guideline on injection site residues - First version (PDF/109.64 KB)
Adopted
First published: 01/10/2004
Last updated: 01/10/2004
Legal effective date: 13/04/2005
EMEA/CVMP/542/03-FINAL -
List item
Overview of comments received on draft guideline on injection site residues (EMEA/CVMP/542/03-FINAL) (PDF/110.09 KB)
First published: 13/01/2005
Last updated: 13/01/2005
EMEA/CVMP/209865/2004